A Novel Drug Delivery System for Diltiazem Hydrochloride
- At: 2013 FIP Congress in Dublin (Ireland)
- Type: Poster
- By: EL HOFFY, Nada (Future University in Egypt, Pharmaceutical Technology Department, Cairo, Egypt)
- Co-author(s): Ammar, Hussein (Future University in Egypt, Cairo, Egypt)
Ibrahim, Magdy (Cairo University, Cairo, Egypt)
Haider, Mohamed (University of Sharjah, Sharjah, United Arab Emirates)
Diltiazem hydrochloride (DLT)
is a class III anti-anginal, and a class IV antiarrhythmic calcium channel blocker undergoing extensive first pass metabolism with an absolute bioavailability of 40%.
in the form of
dosage form may offer an alternative to the oral route, since niosomes protect the hydrophilic drug.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.